David W. Cescon
University Health Network(CA)University of Toronto(CA)Princess Margaret Cancer Centre(CA)Princess Margaret Hospital(NZ)
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Cancer Treatment and Pharmacology, Breast Cancer Treatment Studies
Most-Cited Works
- → Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial(2020)1,740 cited
- → Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer(2022)998 cited
- → Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression(2015)958 cited
- → Functional variants of OCTN cation transporter genes are associated with Crohn disease(2004)842 cited
- → Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study(2018)620 cited
- → CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours(2017)577 cited